Published in Hum Mol Genet on May 01, 1999
Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins. Proc Natl Acad Sci U S A (2000) 3.82
Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation. Mol Biol Cell (2001) 3.41
Huntington toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1. J Cell Biol (2002) 2.76
Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans. Proc Natl Acad Sci U S A (2000) 2.63
Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy. Neuron (2009) 2.26
Effects of heat shock, heat shock protein 40 (HDJ-2), and proteasome inhibition on protein aggregation in cellular models of Huntington's disease. Proc Natl Acad Sci U S A (2000) 1.88
Histone deacetylase inhibitors reduce polyglutamine toxicity. Proc Natl Acad Sci U S A (2001) 1.74
The polyglutamine neurodegenerative protein ataxin 3 regulates aggresome formation. Proc Natl Acad Sci U S A (2005) 1.60
Live-cell imaging reveals divergent intracellular dynamics of polyglutamine disease proteins and supports a sequestration model of pathogenesis. Proc Natl Acad Sci U S A (2002) 1.48
Protein homeostasis in models of aging and age-related conformational disease. Adv Exp Med Biol (2010) 1.48
Neuronal circuitry regulates the response of Caenorhabditis elegans to misfolded proteins. Proc Natl Acad Sci U S A (2011) 1.46
Glutamine/proline-rich PQE-1 proteins protect Caenorhabditis elegans neurons from huntingtin polyglutamine neurotoxicity. Proc Natl Acad Sci U S A (2002) 1.46
Hsp70 and its molecular role in nervous system diseases. Biochem Res Int (2011) 1.44
CDK9 regulates AR promoter selectivity and cell growth through serine 81 phosphorylation. Mol Endocrinol (2010) 1.35
Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy. Hum Mol Genet (2009) 1.32
Nuclear aggresomes form by fusion of PML-associated aggregates. Mol Biol Cell (2005) 1.31
Effect of geldanamycin on androgen receptor function and stability. Cell Stress Chaperones (2002) 1.24
Polyglutamine disease and neuronal cell death. Proc Natl Acad Sci U S A (2000) 1.14
Androgen receptor functional analyses by high throughput imaging: determination of ligand, cell cycle, and mutation-specific effects. PLoS One (2008) 1.13
A cellular perspective on conformational disease: the role of genetic background and proteostasis networks. Curr Opin Struct Biol (2010) 1.13
The formation of peripheral myelin protein 22 aggregates is hindered by the enhancement of autophagy and expression of cytoplasmic chaperones. Neurobiol Dis (2006) 1.13
Huntington's Disease. Cold Spring Harb Perspect Biol (2011) 1.11
Targeting Hsp90/Hsp70-based protein quality control for treatment of adult onset neurodegenerative diseases. Annu Rev Pharmacol Toxicol (2014) 1.09
Hsp40 chaperones promote degradation of the HERG potassium channel. J Biol Chem (2009) 1.09
Abnormalities of germ cell maturation and sertoli cell cytoskeleton in androgen receptor 113 CAG knock-in mice reveal toxic effects of the mutant protein. Am J Pathol (2006) 1.08
The ubiquitin-conjugating enzyme UBCH7 acts as a coactivator for steroid hormone receptors. Mol Cell Biol (2004) 1.08
Ubiquitin conjugation triggers misfolded protein sequestration into quality control foci when Hsp70 chaperone levels are limiting. Mol Biol Cell (2013) 1.07
A polyalanine tract expansion in Arx forms intranuclear inclusions and results in increased cell death. J Cell Biol (2004) 1.05
Mechanisms mediating spinal and bulbar muscular atrophy: investigations into polyglutamine-expanded androgen receptor function and dysfunction. Front Neurol (2013) 1.05
Molecular chaperones as rational drug targets for Parkinson's disease therapeutics. CNS Neurol Disord Drug Targets (2010) 1.04
Microarray analysis of gene expression by skeletal muscle of three mouse models of Kennedy disease/spinal bulbar muscular atrophy. PLoS One (2010) 1.02
Intracellular aggregation of polypeptides with expanded polyglutamine domain is stimulated by stress-activated kinase MEKK1. J Cell Biol (2001) 1.00
Intermediate filament cytoskeleton of the liver in health and disease. Histochem Cell Biol (2008) 0.99
Design of RNAi hairpins for mutation-specific silencing of ataxin-7 and correction of a SCA7 phenotype. PLoS One (2009) 0.98
Reduced intranuclear mobility of APL fusion proteins accompanies their mislocalization and results in sequestration and decreased mobility of retinoid X receptor alpha. Mol Cell Biol (2004) 0.96
The DNAJB6 and DNAJB8 protein chaperones prevent intracellular aggregation of polyglutamine peptides. J Biol Chem (2013) 0.95
cAMP-response element-binding protein and heat-shock protein 70 additively suppress polyglutamine-mediated toxicity in Drosophila. Proc Natl Acad Sci U S A (2005) 0.95
Androgen receptor and Kennedy disease/spinal bulbar muscular atrophy. Horm Behav (2008) 0.92
Co-induction of the heat shock response ameliorates disease progression in a mouse model of human spinal and bulbar muscular atrophy: implications for therapy. Brain (2013) 0.91
Absence of disturbed axonal transport in spinal and bulbar muscular atrophy. Hum Mol Genet (2011) 0.91
Barcoding heat shock proteins to human diseases: looking beyond the heat shock response. Dis Model Mech (2014) 0.90
Androgen receptor mutations associated with androgen insensitivity syndrome: a high content analysis approach leading to personalized medicine. PLoS One (2009) 0.87
A sporadic Parkinson disease model via silencing of the ubiquitin-proteasome/E3 ligase component SKP1A. J Biol Chem (2009) 0.86
Huntington's disease: the past, present, and future search for disease modifiers. Yale J Biol Med (2013) 0.85
Clearance of the mutant androgen receptor in motoneuronal models of spinal and bulbar muscular atrophy. Neurobiol Aging (2013) 0.85
Targeting heat shock proteins to modulate α-synuclein toxicity. Ther Adv Neurol Disord (2014) 0.84
Co-chaperone HSJ1a dually regulates the proteasomal degradation of ataxin-3. PLoS One (2011) 0.84
Drosophila as an In Vivo Model for Human Neurodegenerative Disease. Genetics (2015) 0.83
Cytoplasmic localization and the choice of ligand determine aggregate formation by androgen receptor with amplified polyglutamine stretch. J Cell Biol (2000) 0.82
Localization and importance of the adenovirus E4orf4 protein during lytic infection. J Virol (2008) 0.82
Endoplasmic reticulum stress in spinal and bulbar muscular atrophy: a potential target for therapy. Brain (2014) 0.80
Pathogenic mechanisms and therapeutic strategies in spinobulbar muscular atrophy. CNS Neurol Disord Drug Targets (2013) 0.80
Proteasome-mediated proteolysis of the polyglutamine-expanded androgen receptor is a late event in spinal and bulbar muscular atrophy (SBMA) pathogenesis. J Biol Chem (2015) 0.80
Hydrogen sulfide represses androgen receptor transactivation by targeting at the second zinc finger module. J Biol Chem (2014) 0.80
The life cycle of the 26S proteasome: from birth, through regulation and function, and onto its death. Cell Res (2016) 0.80
Therapeutic approaches to spinal and bulbar muscular atrophy. Trends Pharmacol Sci (2010) 0.80
Holdase activity of secreted Hsp70 masks amyloid-β42 neurotoxicity in Drosophila. Proc Natl Acad Sci U S A (2016) 0.79
Short G-rich oligonucleotides as a potential therapeutic for Huntington's Disease. BMC Neurosci (2006) 0.78
Proteostasis in striatal cells and selective neurodegeneration in Huntington's disease. Front Cell Neurosci (2014) 0.78
Testosterone treatment fails to accelerate disease in a transgenic mouse model of spinal and bulbar muscular atrophy. Dis Model Mech (2011) 0.78
Degradation of oxidized proteins by the proteasome: Distinguishing between the 20S, 26S, and immunoproteasome proteolytic pathways. Mol Aspects Med (2016) 0.77
Polyglutamine androgen receptor-mediated neuromuscular disease. Cell Mol Life Sci (2016) 0.77
Relationship between serum response factor and androgen receptor in prostate cancer. Prostate (2015) 0.76
Heat shock proteins in the retina: Focus on HSP70 and alpha crystallins in ganglion cell survival. Prog Retin Eye Res (2016) 0.76
Inhibition of retrograde transport modulates misfolded protein accumulation and clearance in motoneuron diseases. Autophagy (2017) 0.75
Modulation of Molecular Chaperones in Huntington's Disease and Other Polyglutamine Disorders. Mol Neurobiol (2016) 0.75
Tumor suppressor REIC/DKK-3 and co-chaperone SGTA: Their interaction and roles in the androgen sensitivity. Oncotarget (2016) 0.75
Intracellular kinetics of the androgen receptor shown by multimodal Image Correlation Spectroscopy (mICS). Sci Rep (2016) 0.75
Downregulation of key regulatory proteins in androgen dependent prostate tumor cells by oncolytic reovirus. Virology (2015) 0.75
Co-activator candidate interactions for orphan nuclear receptor NR2E1. BMC Genomics (2016) 0.75
Aging and SKN-1-dependent Loss of 20S Proteasome Adaptation to Oxidative Stress in C. elegans. J Gerontol A Biol Sci Med Sci (2016) 0.75
The Ubiquitination, Disaggregation and Proteasomal Degradation Machineries in Polyglutamine Disease. Front Mol Neurosci (2017) 0.75
ETS Related Gene mediated Androgen Receptor Aggregation and Endoplasmic Reticulum Stress in Prostate Cancer Development. Sci Rep (2017) 0.75
Proteostasis of Huntingtin in Health and Disease. Int J Mol Sci (2017) 0.75
RNA-binding proteins in neurodegeneration: mechanisms in aggregate. Genes Dev (2017) 0.75
The Role of the Heat Shock Protein B8 (HSPB8) in Motoneuron Diseases. Front Mol Neurosci (2017) 0.75
The 11S Proteasomal Activator REGγ Impacts Polyglutamine-Expanded Androgen Receptor Aggregation and Motor Neuron Viability through Distinct Mechanisms. Front Mol Neurosci (2017) 0.75
Measurements of acute cerebral infarction: a clinical examination scale. Stroke (1989) 14.54
Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma (1997) 11.04
A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med (2001) 7.07
Analysis of 1.9 Mb of contiguous sequence from chromosome 4 of Arabidopsis thaliana. Nature (1998) 5.91
The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results. J Neurosurg (1990) 4.72
Multiple independent defective suppressor-mutator transposon insertions in Arabidopsis: a tool for functional genomics. Plant Cell (1999) 4.57
Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nat Genet (1998) 4.27
A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. N Engl J Med (1989) 3.83
Calcium-activated neutral protease (calpain) system: structure, function, and regulation. Physiol Rev (1991) 3.53
Editing of ubiquitin conjugates by an isopeptidase in the 26S proteasome. Nature (1997) 3.47
Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice. Nat Med (1997) 3.46
Molecular interactions of steroid hormone receptor with its enhancer element: evidence for receptor dimer formation. Cell (1988) 3.46
Dynamic association of proteasomal machinery with the centrosome. J Cell Biol (1999) 3.30
Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature (1997) 3.16
Stability of protein pharmaceuticals. Pharm Res (1989) 2.92
Activity of herpes simplex virus type 1 latency-associated transcript (LAT) promoter in neuron-derived cells: evidence for neuron specificity and for a large LAT transcript. J Virol (1990) 2.87
Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. Circulation (1994) 2.84
FRAP reveals that mobility of oestrogen receptor-alpha is ligand- and proteasome-dependent. Nat Cell Biol (2001) 2.76
Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery (1994) 2.74
The International Cooperative Study on the Timing of Aneurysm Surgery. Part 2: Surgical results. J Neurosurg (1990) 2.64
Electron affinic sensitization. V. Radiosensitization of hypoxic bacteria and mammalian cells in vitro by some nitroimidazoles and nitropyrazoles. Radiat Res (1974) 2.61
In situ hybridization analysis of chick embryos in whole mount and tissue sections. Methods Cell Biol (1996) 2.54
Granulomatous mediastinal adenopathy: can endoscopic ultrasound-guided fine-needle aspiration differentiate between tuberculosis and sarcoidosis? Endoscopy (2011) 2.54
Characterization and expression of a cDNA encoding the human androgen receptor. Proc Natl Acad Sci U S A (1989) 2.49
Identification, purification, and characterization of a protein activator (PA28) of the 20 S proteasome (macropain). J Biol Chem (1992) 2.48
Neurologic manifestations of atrial myxoma. A 12-year experience and review. Stroke (1988) 2.30
Laparoscopic kidney transplantation: an initial experience. Am J Transplant (2011) 2.24
Function search in a large transcription factor gene family in Arabidopsis: assessing the potential of reverse genetics to identify insertional mutations in R2R3 MYB genes. Plant Cell (1999) 2.23
Circadian variation in onset of acute ischemic stroke. Arch Neurol (1990) 2.22
Cotranslational biogenesis of NF-kappaB p50 by the 26S proteasome. Cell (1998) 2.21
Colocalization of calcium-dependent protease II and one of its substrates at sites of cell adhesion. Cell (1987) 2.20
Identification, purification, and characterization of a high molecular weight, ATP-dependent activator (PA700) of the 20 S proteasome. J Biol Chem (1994) 2.15
Activation of the human androgen receptor through a protein kinase A signaling pathway. J Biol Chem (1996) 2.15
Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. Am J Pathol (2001) 2.15
Histone H3 phosphorylation is required for the initiation, but not maintenance, of mammalian chromosome condensation. J Cell Sci (1998) 2.11
ACP Broadsheet No 138: May 1993. Gross examination of uterine specimens. J Clin Pathol (1993) 2.08
Demographics of animal bite victims & management practices in a tertiary care institute in Mumbai, Maharashtra, India. Indian J Med Res (2014) 2.06
Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma. Leukemia (2007) 2.03
Ischemic cerebrovascular complications and risk factors in idiopathic hypertrophic subaortic stenosis. Stroke (1991) 2.03
Adjustment of intracuff pressure to prevent aspiration. Anesthesiology (1979) 2.02
Phosphorylation of the nuclear receptor SF-1 modulates cofactor recruitment: integration of hormone signaling in reproduction and stress. Mol Cell (1999) 2.01
Olfactory receptor gene cluster on human chromosome 17: possible duplication of an ancestral receptor repertoire. Hum Mol Genet (1994) 2.00
Rapid diagnosis of respiratory syncytial virus infections in immunocompromised adults. J Clin Microbiol (1996) 1.98
Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology (1999) 1.93
The progesterone receptor stimulates cell-free transcription by enhancing the formation of a stable preinitiation complex. Cell (1990) 1.91
Calcitriol-induced apoptosis in LNCaP cells is blocked by overexpression of Bcl-2. Endocrinology (2000) 1.90
The EphA4 and EphB1 receptor tyrosine kinases and ephrin-B2 ligand regulate targeted migration of branchial neural crest cells. Curr Biol (1997) 1.88
CT and clinical correlations in recent aneurysmal subarachnoid hemorrhage: a preliminary report of the Cooperative Aneurysm Study. Neurology (1983) 1.86
Progression of premature thelarche to central precocious puberty. J Pediatr (1995) 1.85
Proteolytic processing of ovalbumin and beta-galactosidase by the proteasome to a yield antigenic peptides. J Immunol (1994) 1.85
Guidelines for carotid endarterectomy: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke (1998) 1.85
A randomised clinical trial to assess the effect of total enteral and total parenteral nutritional support on metabolic, inflammatory and oxidative markers in patients with predicted severe acute pancreatitis (APACHE II > or =6). Pancreatology (2003) 1.85
The Cdk9 and cyclin T subunits of TAK/P-TEFb localize to splicing factor-rich nuclear speckle regions. J Cell Sci (2001) 1.82
Regulation of progesterone receptor-mediated transcription by phosphorylation. Science (1990) 1.82
Animal models of stroke: are they relevant to human disease? Stroke (1990) 1.82
Frequency, risk factors, anatomy, and course of unilateral neglect in an acute stroke cohort. Neurology (2004) 1.81
The amino-terminal region of the retinoblastoma gene product binds a novel nuclear matrix protein that co-localizes to centers for RNA processing. J Cell Biol (1994) 1.80
3-Hydroxy-3-methylglutaryl-CoA reductase: a transmembrane glycoprotein of the endoplasmic reticulum with N-linked "high-mannose" oligosaccharides. Proc Natl Acad Sci U S A (1983) 1.80
Dominant paternal transmission of Cornelia de Lange syndrome: a new case and review of 25 previously reported familial recurrences. Am J Med Genet (2001) 1.78
Measurements of acute cerebral infarction: lesion size by computed tomography. Stroke (1989) 1.74
Androgen receptor mutations in prostate cancer. Cancer Res (2000) 1.74
A proposed simple method for measurement in the anterior chamber angle: biometric gonioscopy. Ophthalmology (1999) 1.73
Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation. J Biol Chem (1992) 1.70
Anterior choroidal artery territory infarction: a small vessel disease. Stroke (1989) 1.69
Characterization of a novel 350-kilodalton nuclear phosphoprotein that is specifically involved in mitotic-phase progression. Mol Cell Biol (1995) 1.67
Ligand-mediated assembly and real-time cellular dynamics of estrogen receptor alpha-coactivator complexes in living cells. Mol Cell Biol (2001) 1.67
Guidelines for carotid endarterectomy: a statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation (1998) 1.65
A calcitriol analogue, EB1089, inhibits the growth of LNCaP tumors in nude mice. Cancer Res (2000) 1.64
8-Bromo-cyclic AMP induces phosphorylation of two sites in SRC-1 that facilitate ligand-independent activation of the chicken progesterone receptor and are critical for functional cooperation between SRC-1 and CREB binding protein. Mol Cell Biol (2000) 1.64
Prognostic and clinical relevance of pupillary responses, intracranial pressure monitoring, and brainstem auditory evoked potentials in comatose patients with acute supratentorial mass lesions. Crit Care Med (1993) 1.63
Interphysician agreement in the diagnosis of subtypes of acute ischemic stroke: implications for clinical trials. The TOAST Investigators. Neurology (1993) 1.63
Airway hyperreactivity and peripheral airway dysfunction in influenza A infection. Am Rev Respir Dis (1978) 1.62
The cerebellar leucine-rich acidic nuclear protein interacts with ataxin-1. Nature (1997) 1.61
The nuclear corepressors NCoR and SMRT are key regulators of both ligand- and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor. Mol Cell Biol (1998) 1.61
Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet (1994) 1.58
Phosphorylation of steroid receptor coactivator-1. Identification of the phosphorylation sites and phosphorylation through the mitogen-activated protein kinase pathway. J Biol Chem (2000) 1.58
Subnuclear trafficking of estrogen receptor-alpha and steroid receptor coactivator-1. Mol Endocrinol (2000) 1.58
Cerebral infarction in patients with nephrotic syndrome. Stroke (1991) 1.57
Human casein kinase Idelta phosphorylation of human circadian clock proteins period 1 and 2. FEBS Lett (2001) 1.57
Specificity of the ubiquitin isopeptidase in the PA700 regulatory complex of 26 S proteasomes. J Biol Chem (1997) 1.56
Escherichia coli CdtB mediates cytolethal distending toxin cell cycle arrest. Infect Immun (2001) 1.56
Simple bedside additive tool for prediction of in-hospital mortality after percutaneous coronary interventions. Circulation (2001) 1.55
Body mass index as a predictive factor of periodontal therapy outcomes. J Dent Res (2013) 1.55
Activity and regulation of the centrosome-associated proteasome. J Biol Chem (2000) 1.54
Loss of expression of receptor tyrosine kinase family genes PTK7 and SEK in metastatic melanoma. Int J Cancer (1997) 1.53
Accuracy of initial stroke subtype diagnosis in the TOAST study. Trial of ORG 10172 in Acute Stroke Treatment. Neurology (1995) 1.48
Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin Infect Dis (1996) 1.47
Infliximab in active early rheumatoid arthritis. Ann Rheum Dis (2004) 1.47
Identification and partial purification of an ATP-stimulated alkaline protease in rat liver. J Biol Chem (1979) 1.47
Seasonal variation of stroke--does it exist? Neuroepidemiology (1988) 1.46